SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Artemis Therapeutics, Inc. – ‘10-Q’ for 6/30/20 – ‘EX-101.SCH’

On:  Wednesday, 8/12/20, at 2:32pm ET   ·   For:  6/30/20   ·   Accession #:  1178913-20-2374   ·   File #:  0-24431

Previous ‘10-Q’:  ‘10-Q’ on 5/14/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/9/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/21/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/12/20  Artemis Therapeutics, Inc.        10-Q        6/30/20   43:2.2M                                   Z-K Global Ltd./FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    261K 
 2: EX-31.1     Certification -- §302 - SOA'02 -- exhibit_31-1      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02 -- exhibit_32-1      HTML     14K 
10: R1          Document and Entity Information                     HTML     49K 
11: R2          Interim Condensed Consolidated Balance Sheets       HTML     70K 
12: R3          Interim Condensed Consolidated Balance Sheets       HTML     33K 
                (Parenthetical)                                                  
13: R4          Interim Condensed Consolidated Statements of        HTML     39K 
                Comprehensive (Loss) (Unaudited)                                 
14: R5          Interim Condensed Statements of Stockholders'       HTML     43K 
                Equity (Unaudited)                                               
15: R6          Interim Condensed Consolidated Statement of Cash    HTML     40K 
                Flows (Unaudited)                                                
16: R7          General                                             HTML     24K 
17: R8          Significant Accounting Policies                     HTML     30K 
18: R9          Commitments and Contingencies                       HTML     18K 
19: R10         Income Tax                                          HTML     44K 
20: R11         Warrants Issued to Investors                        HTML     21K 
21: R12         Computation of Net Loss per Share                   HTML     48K 
22: R13         Stock Capital                                       HTML     70K 
23: R14         Related Parties                                     HTML     17K 
24: R15         Subsequent Events                                   HTML     17K 
25: R16         Significant Accounting Policies (Policies)          HTML     50K 
26: R17         Income Tax (Tables)                                 HTML     39K 
27: R18         Warrants Issued to Investors (Tables)               HTML     22K 
28: R19         Computation of Net Loss per Share (Tables)          HTML     46K 
29: R20         Stock Capital (Tables)                              HTML     64K 
30: R21         Commitments and Contingencies (Details)             HTML     18K 
31: R22         Income Tax (Narrative) (Details)                    HTML     21K 
32: R23         Income Tax (Schedule of Deferred Income Taxes)      HTML     20K 
                (Details)                                                        
33: R24         Income Tax (Schedule of Net Operating Loss          HTML     18K 
                Carryforwards) (Details)                                         
34: R25         Warrants Issued to Investors (Details)              HTML     19K 
35: R26         Computation of Net Loss per Share (Schedule of      HTML     36K 
                Calculation of Basic Loss Per Share) (Details)                   
36: R27         Stock Capital (Narrative) (Details)                 HTML     44K 
37: R28         Stock Capital (Summary of Stock Option Activity)    HTML     47K 
                (Details)                                                        
38: R29         Stock Capital (Summary of Stock Option Exercise     HTML     34K 
                price) (Details)                                                 
39: R30         Related Parties (Narrative) (Details)               HTML     23K 
40: R31         Subsequent Events (Details)                         HTML     15K 
42: XML         IDEA XML File -- Filing Summary                      XML     73K 
41: EXCEL       IDEA Workbook of Financial Reports                  XLSX     42K 
 4: EX-101.INS  XBRL Instance -- atms-20200630                       XML    678K 
 6: EX-101.CAL  XBRL Calculations -- atms-20200630_cal               XML     68K 
 7: EX-101.DEF  XBRL Definitions -- atms-20200630_def                XML    187K 
 8: EX-101.LAB  XBRL Labels -- atms-20200630_lab                     XML    406K 
 9: EX-101.PRE  XBRL Presentations -- atms-20200630_pre              XML    304K 
 5: EX-101.SCH  XBRL Schema -- atms-20200630                         XSD     84K 
43: ZIP         XBRL Zipped Folder -- 0001178913-20-002374-xbrl      Zip     57K

‘EX-101.SCH’   —   XBRL Schema — atms-20200630

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 5.4a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: ATMS 0620 10Q.xfr; Date: 2020%2D08%2D12T17:39:24Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x80000001 -->
<!-- Field: Doc-Info; Name: Misc; Value: /apZo7xRiXgOn8uHanFcWaqO6bPty5t7qZkxu2h7fUkKryQkaLcGbSx6neLWwWsJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:atms="http://artemistherapeutics.com/20200630" elementFormDefault="qualified" targetNamespace="http://artemistherapeutics.com/20200630">
<annotation>
<appinfo>
<link:roleType roleURI="http://artemistherapeutics.com/role/inks-daei" id="inks-daei">
<link:definition> 00000001 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/inks-ccbs" id="inks-ccbs">
<link:definition> 00000002 - Statement - Interim Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/inks-ccbsp" id="inks-ccbsp">
<link:definition> 00000003 - Statement - Interim Condensed Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/inks-ccsoo" id="inks-ccsoo">
<link:definition> 00000004 - Statement - Interim Condensed Consolidated Statements of Comprehensive (Loss) (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/InterimCondensedStatementsOfStockholdersEquity" id="InterimCondensedStatementsOfStockholdersEquity">
<link:definition> 00000005 - Statement - Interim Condensed Statements of Stockholders' Equity (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/InterimCondensedConsolidatedStatementOfCashFlows" id="InterimCondensedConsolidatedStatementOfCashFlows">
<link:definition> 00000006 - Statement - Interim Condensed Consolidated Statement of Cash Flows (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/inks-bop" id="inks-bop">
<link:definition> 00000007 - Disclosure - GENERAL </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
<link:definition> 00000008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000009 - Disclosure - COMMITMENTS AND CONTINGENCIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/IncomeTax" id="IncomeTax">
<link:definition> 00000010 - Disclosure - INCOME TAX </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/WarrantsIssuedToInvestors" id="WarrantsIssuedToInvestors">
<link:definition> 00000011 - Disclosure - WARRANTS ISSUED TO INVESTORS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/ComputationOfNetLossPerShare" id="ComputationOfNetLossPerShare">
<link:definition> 00000012 - Disclosure - Computation of Net Loss per Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/StockCapital" id="StockCapital">
<link:definition> 00000013 - Disclosure - STOCK CAPITAL </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/RelatedParties" id="RelatedParties">
<link:definition> 00000014 - Disclosure - RELATED PARTIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 00000015 - Disclosure - SUBSEQUENT EVENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
<link:definition> 00000016 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/IncomeTaxTables" id="IncomeTaxTables">
<link:definition> 00000017 - Disclosure - INCOME TAX (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/WarrantsIssuedToInvestorsTables" id="WarrantsIssuedToInvestorsTables">
<link:definition> 00000018 - Disclosure - WARRANTS ISSUED TO INVESTORS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/ComputationOfNetLossPerShareTables" id="ComputationOfNetLossPerShareTables">
<link:definition> 00000019 - Disclosure - Computation of Net Loss per Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/StockCapitalTables" id="StockCapitalTables">
<link:definition> 00000020 - Disclosure - STOCK CAPITAL (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
<link:definition> 00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/IncomeTaxNarrativeDetails" id="IncomeTaxNarrativeDetails">
<link:definition> 00000022 - Disclosure - INCOME TAX (Narrative) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/IncomeTaxScheduleOfDeferredIncomeTaxesDetails" id="IncomeTaxScheduleOfDeferredIncomeTaxesDetails">
<link:definition> 00000023 - Disclosure - INCOME TAX (Schedule of Deferred Income Taxes) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/IncomeTaxScheduleOfNetOperatingLossCarryforwardsDetails" id="IncomeTaxScheduleOfNetOperatingLossCarryforwardsDetails">
<link:definition> 00000024 - Disclosure - INCOME TAX (Schedule of Net Operating Loss Carryforwards) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/WarrantsIssuedToInvestorsDetails" id="WarrantsIssuedToInvestorsDetails">
<link:definition> 00000025 - Disclosure - WARRANTS ISSUED TO INVESTORS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/ComputationOfNetLossPerShareScheduleOfCalculationOfBasicLossPerShareDetails" id="ComputationOfNetLossPerShareScheduleOfCalculationOfBasicLossPerShareDetails">
<link:definition> 00000026 - Disclosure - Computation of Net Loss per Share (Schedule of Calculation of Basic Loss Per Share) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/StockCapitalNarrativeDetails" id="StockCapitalNarrativeDetails">
<link:definition> 00000027 - Disclosure - STOCK CAPITAL (Narrative) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/StockCapitalSummaryOfStockOptionActivityDetails" id="StockCapitalSummaryOfStockOptionActivityDetails">
<link:definition> 00000028 - Disclosure - STOCK CAPITAL (Summary of Stock Option Activity) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/StockCapitalSummaryOfStockOptionExercisePriceDetails" id="StockCapitalSummaryOfStockOptionExercisePriceDetails">
<link:definition> 00000029 - Disclosure - STOCK CAPITAL (Summary of Stock Option Exercise price) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/RelatedPartiesNarrativeDetails" id="RelatedPartiesNarrativeDetails">
<link:definition> 00000030 - Disclosure - RELATED PARTIES (Narrative) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://artemistherapeutics.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
<link:definition> 00000031 - Disclosure - SUBSEQUENT EVENTS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="atms-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="atms-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="atms-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="atms-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
<element id="atms_CompensationRelatedToShareOptionPlan" name="CompensationRelatedToShareOptionPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncreaseDecreaseInOtherAccountsReceivablesAndPrepaidExpenses" name="IncreaseDecreaseInOtherAccountsReceivablesAndPrepaidExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_MergerAgreementRequiredFinancingAmount" name="MergerAgreementRequiredFinancingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_AdoptionOfNewAccountingStandard" name="AdoptionOfNewAccountingStandard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="atms_UnauditedInterimFinancialStatementsPoliciesTextBlock" name="UnauditedInterimFinancialStatementsPoliciesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="atms_ArtemisTherapeuticsMember" name="ArtemisTherapeuticsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_UnitedStatesTaxAuthorityMember" name="UnitedStatesTaxAuthorityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_ReceivablesOnAccountOfSharesMember" name="ReceivablesOnAccountOfSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IssuancedateOneMember" name="IssuancedateOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_TwoThousandsSeventeenMember" name="TwoThousandsSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_TwoThousandsEighteenMember" name="TwoThousandsEighteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_NewIssueSeriesAPreferredStockMember" name="NewIssueSeriesAPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WithinSevenMonthsOfClosingMember" name="WithinSevenMonthsOfClosingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WithinTwelveMonthsOfEffectiveTimeMember" name="WithinTwelveMonthsOfEffectiveTimeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WithinTwentyFourMonthsOfEffectiveTimeMember" name="WithinTwentyFourMonthsOfEffectiveTimeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_OctoberTwoThousandSeventeenMember" name="OctoberTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_RangeOneMember" name="RangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_RangeTwoMember" name="RangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_RangeThreeMember" name="RangeThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_PreferredStockSeriesAMember" name="PreferredStockSeriesAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_PreferredStockSeriesCMember" name="PreferredStockSeriesCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_RangeFourMember" name="RangeFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="atms_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncreaseInLongTermWarrantLiability" name="IncreaseInLongTermWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_SignificantAccountingPoliciesAbstract" name="SignificantAccountingPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_CommitmentsAndContingenciesAbstract" name="CommitmentsAndContingenciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncomeTaxAbstract" name="IncomeTaxAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WarrantsIssuedToInvestorsAbstract" name="WarrantsIssuedToInvestorsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_ComputationOfNetLossPerShareAbstract" name="ComputationOfNetLossPerShareAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_StockCapitalAbstract" name="StockCapitalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_SignificantAccountingPoliciesPolicyAbstract" name="SignificantAccountingPoliciesPolicyAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncomeTaxTablesAbstract" name="IncomeTaxTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WarrantsIssuedToInvestorsTablesAbstract" name="WarrantsIssuedToInvestorsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_ComputationOfNetLossPerShareTablesAbstract" name="ComputationOfNetLossPerShareTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_StockCapitalTablesAbstract" name="StockCapitalTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_CommitmentsAndContingenciesDetailsAbstract" name="CommitmentsAndContingenciesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncomeTaxNarrativeDetailsAbstract" name="IncomeTaxNarrativeDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncomeTaxScheduleOfDeferredIncomeTaxesDetailsAbstract" name="IncomeTaxScheduleOfDeferredIncomeTaxesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IncomeTaxScheduleOfNetOperatingLossCarryforwardsDetailsAbstract" name="IncomeTaxScheduleOfNetOperatingLossCarryforwardsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WarrantsOptionsDetailsAbstract" name="WarrantsOptionsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_WarrantReverseStockSplit" name="WarrantReverseStockSplit" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableMaturityDate" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableMaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item"/>
<element id="atms_ComputationOfNetLossPerShareScheduleOfCalculationOfBasicLossPerShareDetailsAbstract" name="ComputationOfNetLossPerShareScheduleOfCalculationOfBasicLossPerShareDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_StockCapitalDetailsAbstract" name="StockCapitalDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="atms_FinanceExpenseOnWarrant" name="FinanceExpenseOnWarrant" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_FinanceIncomeOnWarrant" name="FinanceIncomeOnWarrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="atms_IssuanceOfSharesAdditionalPercentageOfSharesThatCanBePurchased" name="IssuanceOfSharesAdditionalPercentageOfSharesThatCanBePurchased" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="atms_AdditionalSharesPercentageOfPurchasePrice" name="AdditionalSharesPercentageOfPurchasePrice" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="atms_StockCapitalSummaryOfStockOptionActivityDetailsAbstract" name="StockCapitalSummaryOfStockOptionActivityDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
</schema>

↑Top
Filing Submission 0001178913-20-002374   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., May 4, 3:51:43.1am ET